Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-002783

Chief Financial Officer sold 30,000 shares at $35.00 ($1,050,000)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2023-01-23 Option exercise +12,500 $2.08 $26,000 96,924 D: show line 1 in the form
Cummings Keith Lamont Chief Financial Officer 2023-01-23 Option exercise +17,500 $6.22 $108,850 114,424 D: show line 2 in the form
Cummings Keith Lamont Chief Financial Officer 2023-01-23 Sale −30,000 $35.00 $1,050,000 84,424 D: show line 3 in the form
Open-market sales · 30,000 sh · avg $35.00 · $1,050,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2023-01-23 Option exercise · Stock Option (right to buy) −12,500 133,597 D: show line 4 in the form
Cummings Keith Lamont Chief Financial Officer 2023-01-23 Option exercise · Stock Option (right to buy) −17,500 18,198 D: show line 5 in the form
Loading xslF345X03/form4.xml…